- Home
- ITRM vs SNAL Comparison
ITRM vs SNAL Comparison
Compare ITRM & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRM
- SNAL
- Stock Information
- Founded
- ITRM 2015
- SNAL 2000
- Country
- ITRM Ireland
- SNAL United States
- Employees
- ITRM N/A
- SNAL N/A
- Industry
- ITRM Biotechnology: Pharmaceutical Preparations
- SNAL Computer Software: Prepackaged Software
- Sector
- ITRM Health Care
- SNAL Technology
- Exchange
- ITRM Nasdaq
- SNAL Nasdaq
- Market Cap
- ITRM 40.0M
- SNAL 45.1M
- IPO Year
- ITRM 2018
- SNAL 2022
- Fundamental
- Price
- ITRM $0.48
- SNAL $0.90
- Analyst Decision
- ITRM Strong Buy
- SNAL
- Analyst Count
- ITRM 1
- SNAL 0
- Target Price
- ITRM $9.00
- SNAL N/A
- AVG Volume (30 Days)
- ITRM 1.2M
- SNAL 26.8K
- Earning Date
- ITRM 11-14-2025
- SNAL 11-12-2025
- Dividend Yield
- ITRM N/A
- SNAL N/A
- EPS Growth
- ITRM N/A
- SNAL N/A
- EPS
- ITRM N/A
- SNAL N/A
- Revenue
- ITRM $390,000.00
- SNAL $82,330,445.00
- Revenue This Year
- ITRM N/A
- SNAL $13.87
- Revenue Next Year
- ITRM $482.25
- SNAL $26.20
- P/E Ratio
- ITRM N/A
- SNAL N/A
- Revenue Growth
- ITRM N/A
- SNAL N/A
- 52 Week Low
- ITRM $0.36
- SNAL $0.64
- 52 Week High
- ITRM $3.02
- SNAL $3.42
- Technical
- Relative Strength Index (RSI)
- ITRM 41.91
- SNAL 39.31
- Support Level
- ITRM $0.36
- SNAL $0.88
- Resistance Level
- ITRM $0.49
- SNAL $0.91
- Average True Range (ATR)
- ITRM 0.05
- SNAL 0.04
- MACD
- ITRM -0.00
- SNAL -0.01
- Stochastic Oscillator
- ITRM 43.47
- SNAL 0.06
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About SNAL Snail Inc.
Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.